Table 3.
Baseline characteristics comparison between atrial cardiopathy and no atrial cardiopathy in patients with ESUS.
|
Atrial cardiopathy (n = 45) |
No atrial cardiopathy (n = 60) |
P-value | |
|---|---|---|---|
| Age, y, mean (SD) | 65.28 ± 13.17 | 56.00 ± 14.54 | 0.001 |
| Sex, %, male | 71.11 | 61.67 | 0.313 |
| Hypertension, % | 71.11 | 51.67 | 0.044 |
| Diabetes mellitus, % | 26.67 | 18.33 | 0.307 |
| CAD, % | 22.22 | 10.00 | 0.085 |
| Prior stroke, % | 17.78 | 10.00 | 0.246 |
| Smoke, % | 46.67 | 40.00 | 0.495 |
| NIHSS, M(Q) | 4.00 (1.00, 8.50) | 3.00 (2.00, 8.00) | 0.995 |
| Fazekas, M(Q) | 1.00 (1.00, 3.00) | 1.00 (0.00, 3.00) | 0.562 |
| TC, mean (SD) | 3.67 ± 0.90 | 3.89 ± 0.82 | 0.120 |
| TG, M (Q) | 1.09 (0.86, 1.39) | 1.34 (0.87, 1.76) | 0.100 |
| HDL, M (Q) | 1.02 (0.87, 1.27) | 0.91 (0.75, 1.11) | 0.157 |
| LDL, mean (SD) | 2.05 ± 0.79 | 2.24 ± 2.22 | 0.083 |
| Hb, mean (SD) | 127.72 ± 21.27 | 141.94 ± 19.65 | 0.001 |
| D-dimer, M (Q) | 1.02 (0.59, 2.30) | 0.70 (0.39, 1.33) | 0.015 |
| EF, M (Q) | 66.00 (60.50, 70.00) | 69.00 (65.00, 42.00) | 0.026 |
| LVDD, mean (SD) | 50.16 ± 5.48 | 48.11 ± 3.49 | 0.004 |
| LVDS, M (Q) | 31.00 (29.00, 34.50) | 30.00 (27.00,32.00) | 0.008 |
| PR interval, mean (SD) | 165.24 ± 30.95 | 155.93 ± 19.33 | 0.009 |
| Single APB, M (Q) | 65.00 (5.50, 520.5) | 9.50 (0.00, 40.25) | 0.001 |
| Coupling APB, M (Q) | 2.00 (0.00, 13.50) | 0.00 (0.00, 2.75) | 0.011 |
| Atrial tachycardia, M (Q) | 0.00 (0.00, 3.50) | 0.00 (0.00, 1.00) | 0.013 |
IS, ischemic stroke; ESUS, embolic strokes of undetermined source; CAD, coronary heart disease; NIHSS, the national institutes of health stroke scale; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; Hb, hemoglobin; EF, ejection fraction; LVDD, left ventricular end diastolic diameter; LVDS, left ventricular end diastolic systolic diameter; APB, atrial premature beat.